Literature DB >> 25699490

Performance of vancomycin and teicoplanin disk diffusion test in isogenic vancomycin non-susceptible Staphylococcus aureus.

Sujintana Wongthong1, Karnjana Dutchanutouch, Viladda Namsaengkang, Aroonwadee Chanawong, Chotechana Wilailuckana, Aroonlug Lulitanond.   

Abstract

INTRODUCTION: Detection of heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) is currently problematic. Although the population analysis profile with area under the curve (PAP-AUC) is the gold standard for detecting hVISA strains, this method is time consuming. This study aimed to induce vancomycin non-susceptible Staphylococcus aureus isolates in methicillin-resistant S. aureus (MRSA) and to determine the performance of the vancomycin and teicoplanin disk diffusion test for screening of induced and natural vancomycin non-susceptible isolates.
METHODOLOGY: Vancomycin resistance was induced in vitro in methicillin-resistant S. aureus by serial passage in media with increasing vancomycin concentrations. All test isolates were confirmed for their susceptibility to vancomycin by using a PAP-AUC method. The performance of the vancomycin and teicoplanin disk diffusion test for detecting both induced and natural hVISA/VISA isolates was analyzed using the MedCal program version 10.2.0.
RESULTS: The induction test revealed that 42 of 78 MRSA isolates (53.8%) became hVISA and/or VISA. Using 10, 15, 20, 30 µg vancomycin disks and a 30 µg teicoplanin disk, the highest performance (88.9%) for hVISA/VISA detection (71.1%), sensitivity, 100% specificity, 100% positive predictive value, and 75% negative predictive value) was obtained when a 20 µg vancomycin disk was used at 1.0 McFarland inoculum for a 24-hour incubation.
CONCLUSIONS: The results indicated that using a 20 µg vancomycin disk and bacterial inoculum of 1.0 McFarland is simple to perform and provides a primary result for hVISA/VISA screening within 24 hours.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25699490     DOI: 10.3855/jidc.5059

Source DB:  PubMed          Journal:  J Infect Dev Ctries        ISSN: 1972-2680            Impact factor:   0.968


  3 in total

1.  VraR Binding to the Promoter Region of agr Inhibits Its Function in Vancomycin-Intermediate Staphylococcus aureus (VISA) and Heterogeneous VISA.

Authors:  Yuanyuan Dai; Wenjiao Chang; Changcheng Zhao; Jing Peng; Liangfei Xu; Huaiwei Lu; Shusheng Zhou; Xiaoling Ma
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

2.  Evolution and antimicrobial resistance of enterococci isolated from Pecorino and goat cheese manufactured on-farm in an area facing constraints as per EU Regulation 1305/2013 in Umbria, Italy.

Authors:  Luca Grispoldi; Musafiri Karama; Saeed El-Ashram; Cristina Saraiva; Juan García-Díez; Athanasios Chalias; Beniamino Cenci-Goga
Journal:  Ital J Food Saf       Date:  2022-06-29

3.  Synergistic effect of vancomycin combined with cefotaxime, imipenem, or meropenem against Staphylococcus aureus with reduced susceptibility to vancomycin

Authors:  Arpasiri Srisrattakarn; Chonthicha Chaiyapoke; Sirikarn Booncharoen; Sujintana Wongthong; Aroonwadee Chanawong; Patcharaporn Tippayawat; Ratree Tavichakorntrakool; Aroonlug Lulitanond
Journal:  Turk J Med Sci       Date:  2021-08-30       Impact factor: 0.973

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.